Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue
Phenylbutyrate turns on DJ-1 allowing it to activate antioxidant programmes including glutathione synthesis. The drug is in clinical trials. Risk factors: Parkinson's diseaseKegg pathwaysParkinson's
No comments:
Post a Comment